Aquestive Therapeutics, Inc. (AQST) Dividend History

Aquestive Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing medicines to address unmet medical needs. The company specializes in developing proprietary formulations of drugs for respiratory, epilepsy, and other disorders, utilizing its core patent-protected oral and transdermal technologies.

30 Technology Drive, Warren, NJ, 07059
Phone: 908-941-1900
Website: https://www.aquestive.com

Dividend History

Aquestive Therapeutics, Inc. currently does not pay dividends

Company News

  • Aquestive Therapeutics announced the promotion of Sherry Korczynski to Chief Commercial Officer, focusing on driving the commercial strategy for Anaphylm, a breakthrough oral epinephrine delivery product for anaphylaxis treatment.

    GlobeNewswire Inc.
    Featured Companies: LLY
  • Innovation is expected to continue to drive the growth of the Zacks Medical-Drugs industry. HRTX, BVS, AQST, ACRV and CRDL may prove to be good additions to one's portfolio.

    Zacks Investment Research
    Featured Companies: ACRV BVS CRDL HRTX
  • Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-quarter net sales guidance. STAAR Surgical shares jumped 13.3% to $44.30 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers TC Biopharm (Holdings) Plc (NASDAQ: TCBP) shares climbed 130.1% to $2.9790. TCBP announced execution of non-binding letter of intent for acquisition of NK Platform Technologies. Allurion Technologies Inc. (NASDAQ: ALUR) gained 70% to $2.8801 after the company announced the commercial availability of its Virtual Care Suite in the United States. Also, Chardan Capital initiated coverage on the stock with a Buy rating and announced a $5 price target. Tevogen Bio Holdings Inc. (NASDAQ: TVGN) shares climbed 40.6% to $3.58. Tevogen Bio, on Wednesday, appointed Tapan V Shah as Head of Investor Relations and Corporate Development. HWH International Inc. (NASDAQ: HWH) gained 38.8% to $2.1765. Candel Therapeutics, Inc. (NASDAQ: CADL) rose 36.3% to $2.2899 after the company announced interim data from the randomized phase 2 clinical trial of CAN-2409 in non-metastatic prostate cancer. MacroGenics, Inc. (NASDAQ: MGNX) climbed 27.8% to $17.47. MacroGenics announced TAMARACK study data will not be presented at the ASCO Annual Meeting. E-Home Household Service Holdings Limited (NASDAQ: EJH) gained 27% to $2.22. Reliance Global Group, Inc. (NASDAQ: RELI) gained 24.6% to $0.46 after the company reported FY23 earnings. Simulations Plus, Inc. (NASDAQ: SLP) rose 22.5% to $47.12 after the company posted better-than-expected results for its second quarter. Vast Renewables Limited (NASDAQ: VSTE) gained 22.3% to $8.81. Sportsman's Warehouse Holdings, Inc. (NASDAQ: SPWH) gained 21.3% to $3.7950 following a narrower-than-expected quarterly loss. Gorilla Technology Group Inc. (NASDAQ: GRRR) jumped 19% to $0.8729 after the company reported a year-over-year increase in FY23 sales results. Levi Strauss & Co. (NYSE: LEVI) shares rose 18.3% to $22.10 after the company reported upbeat earnings ...

    Benzinga
Page data last updated 07/23/2025 09:39:37 UTC